We are live on ! Find out more
BNTC icon

Benitec Biopharma
BNTC

2 hedge funds and large institutions have $3.97M invested in Benitec Biopharma in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$3.7M
2
RCM
RA Capital Management
Massachusetts
+$1.03M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$3.11M +$3.7M +1,981 New
RCM
2
RA Capital Management
Massachusetts
$864K +$1.03M +551 New

BNTC Hedge Fund Activity: Q3 2015 in Review

2 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma (BNTC) for Q3 2015, worth a combined $3.97M.

Buyers outnumbered sellers: 2 funds opened new BNTC positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $3.7M.

  • 2 institutional investors held Benitec Biopharma (BNTC) as of Q3 2015, up from 0 in Q2 2015.
  • Funds reported $3.97M of Benitec Biopharma stock for Q3 2015.
  • 2 funds opened new Benitec Biopharma positions in Q3 2015 and 0 closed out, a net change of +2 holders.
  • The largest Benitec Biopharma buyer in Q3 2015 was Sabby Management, an estimated $3.7M added.

Based on aggregated 13F filings for Q3 2015.